WO1990004387A3 - Composition de traitement de symptomes relatifs au manque de tabac - Google Patents
Composition de traitement de symptomes relatifs au manque de tabac Download PDFInfo
- Publication number
- WO1990004387A3 WO1990004387A3 PCT/US1989/004743 US8904743W WO9004387A3 WO 1990004387 A3 WO1990004387 A3 WO 1990004387A3 US 8904743 W US8904743 W US 8904743W WO 9004387 A3 WO9004387 A3 WO 9004387A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- compositions
- withdrawal symptoms
- treating tobacco
- tobacco withdrawal
- disturbances
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/15—Oximes (>C=N—O—); Hydrazines (>N—N<); Hydrazones (>N—N=) ; Imines (C—N=C)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Addiction (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP89912045A EP0440704B1 (fr) | 1988-10-26 | 1989-10-25 | Composition de traitement de symptomes relatifs au manque de tabac |
DE68924537T DE68924537T2 (de) | 1988-10-26 | 1989-10-25 | Zusammensetzung zur behandlung der symptome verursacht durch beseitigung von tabak. |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US262,625 | 1988-10-26 | ||
US07/262,625 US4999382A (en) | 1988-10-26 | 1988-10-26 | Compositions for treating tobacco withdrawal symptoms and methods for their use |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1990004387A2 WO1990004387A2 (fr) | 1990-05-03 |
WO1990004387A3 true WO1990004387A3 (fr) | 1990-06-28 |
Family
ID=22998317
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1989/004743 WO1990004387A2 (fr) | 1988-10-26 | 1989-10-25 | Composition de traitement de symptomes relatifs au manque de tabac |
Country Status (7)
Country | Link |
---|---|
US (1) | US4999382A (fr) |
EP (1) | EP0440704B1 (fr) |
JP (1) | JP2997280B2 (fr) |
AT (1) | ATE128864T1 (fr) |
CA (1) | CA2001572C (fr) |
DE (1) | DE68924537T2 (fr) |
WO (1) | WO1990004387A2 (fr) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK0415612T3 (da) * | 1989-08-30 | 1993-12-13 | Pfizer | Anvendelse af sertralin til behandling af afhængigheder af kemiske stoffer |
US5455254A (en) * | 1991-02-15 | 1995-10-03 | Mondadori; Cesare | Substituted benzofuranylpiperidine as a nootropic agent |
DK36391D0 (da) * | 1991-03-01 | 1991-03-01 | Lundbeck & Co As H | Anvendelse af piperidylsubstituerede indolderivater til behandling af stofmisbrug |
BE1005200A3 (fr) * | 1991-08-27 | 1993-05-25 | Vandendael Kathleen Mariette | Utilisation de tryptophane et composition nutritionnelle comprenant du tryptophane. |
AU2446895A (en) * | 1994-04-22 | 1995-11-16 | Assistance Publique - Hopitaux De Paris | Use of mao-a inhibitors for the manufacture of a medicament in the treatment of tobacco withdrawal symptoms in smokers |
JP3839049B2 (ja) * | 1994-06-03 | 2006-11-01 | テムド トラスト | メタ位置換のアリルアルキルアミン類ならびに治療および診断のためのその使用 |
US6004990A (en) * | 1994-06-03 | 1999-12-21 | Zebra Pharmaceuticals | Meta substituted arylalkylamines and therapeutic and diagnostic uses therefor |
BR9501972A (pt) * | 1995-05-09 | 1997-08-26 | Tostes Luiz Roberto Mallat | Composição farmacêutica metodo para tratamento de dependência ou abuso de álcool e método para tratamento de distúrbios psiquiátricos geneticamente relacionados ao alcoolismo |
US6316022B1 (en) | 1995-06-07 | 2001-11-13 | Noven Pharmaceuticals, Inc. | Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures |
NZ309980A (en) | 1995-06-07 | 2001-06-29 | Noven Pharma | Transdermal composition containing a blend of one or more polymers, one or more drugs that has a low molecular weight and is liquid at room temperature |
US6512010B1 (en) * | 1996-07-15 | 2003-01-28 | Alza Corporation | Formulations for the administration of fluoxetine |
US5760049A (en) * | 1997-02-21 | 1998-06-02 | Synapse Pharmaceuticals International, Inc. | Method for controlling tobacco use and alleviating withdrawal symptoms due to cessation of tobacco use |
US6166032A (en) * | 1997-02-07 | 2000-12-26 | Synapse Pharmaceuticals International, Inc. | Method for controlling tobacco use and alleviating withdrawal symptoms due to cessation of tobacco use |
US6203817B1 (en) | 1997-02-19 | 2001-03-20 | Alza Corporation | Reduction of skin reactions caused by transdermal drug delivery |
US5910319A (en) * | 1997-05-29 | 1999-06-08 | Eli Lilly And Company | Fluoxetine enteric pellets and methods for their preparation and use |
US6908631B1 (en) | 1997-12-01 | 2005-06-21 | Nicogen, Inc. | Therapeutic and diagnostic methods dependent on CYP2A enzymes |
US6333357B1 (en) * | 1999-11-05 | 2001-12-25 | Be Able, Llc | Behavior chemotherapy |
US6617361B2 (en) | 1999-11-05 | 2003-09-09 | Be Able, Llc | Behavior chemotherapy |
EP1274444B1 (fr) * | 2000-03-16 | 2013-05-15 | THE McLEAN HOSPITAL CORPORATION | Cdp-choline et uridine pour le traitement de l'abus d'alcool |
IL154378A0 (en) * | 2000-08-16 | 2003-09-17 | Upjohn Co | Compounds for the treatment of addictive disorders |
CN100430066C (zh) * | 2002-11-08 | 2008-11-05 | 麦克莱恩医院 | 用于烟草依赖性和戒断治疗的化合物 |
JP2007508315A (ja) * | 2003-10-08 | 2007-04-05 | ザ マクレーン ホスピタル コーポレーション | ω−3脂肪酸を含む組み合わせを用いて、精神障害、物質乱用障害、および他の障害を治療する方法 |
WO2005034874A2 (fr) * | 2003-10-08 | 2005-04-21 | The Mclean Hospital Corporation | Efficacite amelioree d'une therapie aux acides gras omega-3 dans le traitement de troubles psychiatriques et d'autres indications |
DK1691811T3 (da) | 2003-12-11 | 2014-10-20 | Sunovion Pharmaceuticals Inc | Kombination af et sedativ og en neurotransmittermodulator og fremgangsmåder til forbedring af søvnkvaliteten og behandling af depression |
EP1765364A4 (fr) * | 2004-06-10 | 2010-09-22 | Mclean Hospital Corp | Pyrimidines, tels que cytidine, dans les traitements de patients souffrant de troubles bipolaires |
EP1765075A4 (fr) * | 2004-06-10 | 2010-11-10 | Mclean Hospital Corp | Pyrimidines, notamment de l'uridine, utilisees dans des traitements sur des patients atteints de troubles bipolaires |
US7947661B2 (en) * | 2004-08-11 | 2011-05-24 | The Mclean Hospital Corporation | Compounds for the treatment of marihuana dependence, withdrawal, and usage |
US20100041621A1 (en) * | 2008-08-15 | 2010-02-18 | Perry Renshaw | Methods and compositions for improving cognitive performance |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0153083A2 (fr) * | 1984-02-06 | 1985-08-28 | Eli Lilly And Company | -4,Dialkylaminotetrahydrobenz[c,d]indoles substitués en position 6- |
WO1988003801A1 (fr) * | 1986-11-21 | 1988-06-02 | Glaxo Group Limited | Medicaments pour le traitement ou la prevention d'un syndrome de reaction a la privation |
EP0302008A2 (fr) * | 1987-07-11 | 1989-02-01 | Sandoz Ag | Antagonistes de 5HT-3 pour la prévention de dépendance |
EP0314984A2 (fr) * | 1987-10-31 | 1989-05-10 | Troponwerke GmbH & Co. KG | Application des dérivés de la 2-pyrimidinyl-1-pipérazine |
-
1988
- 1988-10-26 US US07/262,625 patent/US4999382A/en not_active Expired - Lifetime
-
1989
- 1989-10-25 DE DE68924537T patent/DE68924537T2/de not_active Expired - Fee Related
- 1989-10-25 EP EP89912045A patent/EP0440704B1/fr not_active Expired - Lifetime
- 1989-10-25 WO PCT/US1989/004743 patent/WO1990004387A2/fr active IP Right Grant
- 1989-10-25 AT AT89912045T patent/ATE128864T1/de not_active IP Right Cessation
- 1989-10-25 JP JP1511314A patent/JP2997280B2/ja not_active Expired - Fee Related
- 1989-10-26 CA CA002001572A patent/CA2001572C/fr not_active Expired - Fee Related
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0153083A2 (fr) * | 1984-02-06 | 1985-08-28 | Eli Lilly And Company | -4,Dialkylaminotetrahydrobenz[c,d]indoles substitués en position 6- |
WO1988003801A1 (fr) * | 1986-11-21 | 1988-06-02 | Glaxo Group Limited | Medicaments pour le traitement ou la prevention d'un syndrome de reaction a la privation |
EP0302008A2 (fr) * | 1987-07-11 | 1989-02-01 | Sandoz Ag | Antagonistes de 5HT-3 pour la prévention de dépendance |
EP0314984A2 (fr) * | 1987-10-31 | 1989-05-10 | Troponwerke GmbH & Co. KG | Application des dérivés de la 2-pyrimidinyl-1-pipérazine |
Non-Patent Citations (12)
Title |
---|
Am. J. Psychiatry, Volume 146, No. 3, March 1989, American Psychiatric Association, N.B. EDWARDS et al.: "Doxepin as an Adjunct to Smoking Cessation: a Double-Blind Pilot Study", pages 373-376 see the whole article, with Emphasis on page 375, left-hand column, lines 8-19 * |
Am. J. Psychiatry, Volume 146, No. 9, September 1989 C.M. CHURCHILL et al.: "Antidepressants and Cessation of Smoking", pages 1238-1239 see the whole letter * |
Arch. Gen. Psychiatry, Volume 46, No. 3, March 1989, F. GAWIN: "Buspirone Reduces Smoking", pages 288-289 see the whole letter * |
Br. J. Pharmacol., Volume 41, No. 2, February 1971, G.L.S. PAWAN et al.: "Preliminary Study on the Effects of Fenfluramine Derivative, 'S992' in Man", pages 416P-417P see page 417P, paragraph 1 * |
Can. Med. Assoc. J., Volume 107, No. 8, 21 October 1972, E. WONG: "Effect of Surmontil on the Cigarette Habit", page 727 see the whole letter * |
Clin. Pharmacol. Ther., Volume 46, No. 3, September 1989, C.A. NARANJO et al.: "Differential effects of Viqualine on Alcohol Intake and Other Consummatory Behaviors", pages 301-306 see summary * |
International Journal of Obesity, Volume 6, No. 4, 1982, P. TURNER et al.: "The Peripheral Actions of Antiobesity Drugs", pages 411-415 see page 412, lines 1-3 * |
J. Clin. Psychopharmacol., Volume 7, No. 6, December 1987, E.M. SELLERS et al.: "Do Serotonin Uptake Inhibitors Decrease Smoking? Observations in a Group of Heavy Drinkers", pages 417-420 see the title * |
Molecular Pharmacology, Volume 33, No. 3, March 1988, The American Society for Pharmacology and Experimental Therapeutics, D. HOYER et al.: "Identification of Serotonin 5-HT3 Recognition Sites in Membranes of N1E-115 Neuroblastoma Cells by Radioligand Binding", pages 303-309 see summary * |
Munch. Med. Wochenschr., Volume 112, No. 51, 18 December 1970, B. LUBAN-PLOZZA: "Das Rauchen und die Moglichkeiten der Raucher-Ent-Wohnung", pages 2322-2327 see summary; page 2325, left-hand column, lines 15-22; page 2326, right-hand column; page 2327, left-hand column * |
Psychosom. Med., Volume 33, No. 6, November-December 1971, M.A. JACOBS et al.: "Interaction of Personality and Treatment Conditions Associated with Success in a Smoking Control Program", pages 545-556 see page 546, right-hand column, lines 15-35; page 547, left-hand column; page 548, table 1; page 549, table 2 * |
Psychosomatics, Volume 29, No. 2, Spring 1988, The Academy of Psychosomatic Medicine, N.B. EDWARDS et al.: "Doxepin in the Treatment of Nicotine Withdrawal", pages 203-206 see Abstract * |
Also Published As
Publication number | Publication date |
---|---|
JPH04501413A (ja) | 1992-03-12 |
JP2997280B2 (ja) | 2000-01-11 |
ATE128864T1 (de) | 1995-10-15 |
EP0440704B1 (fr) | 1995-10-11 |
CA2001572C (fr) | 2001-01-02 |
WO1990004387A2 (fr) | 1990-05-03 |
CA2001572A1 (fr) | 1990-04-26 |
DE68924537D1 (de) | 1995-11-16 |
US4999382A (en) | 1991-03-12 |
EP0440704A1 (fr) | 1991-08-14 |
DE68924537T2 (de) | 1996-08-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1990004387A3 (fr) | Composition de traitement de symptomes relatifs au manque de tabac | |
UA41369C2 (uk) | Нікотинова таблетка та спосіб лікування від куріння | |
DK1056856T3 (da) | Modificeret ciliarneurotrofisk faktor samt fremgangsmåder til dannelse og anvendelse deraf | |
HUT74004A (en) | Inhibitors of beta-amyloid protein production | |
ATE232384T1 (de) | Zusammensetzungen zur behandlung von nikotinabhängigkeit, enthaltend mecamylamin und bupropion | |
LV10692A (lv) | Nikotinu necaurlaidigs konteiners un ta pagatavosanas panemiens | |
EA199700119A1 (ru) | Соединения, оказывающие эффекты на системы, связанные с серотонином | |
IE893712L (en) | Quinuclidines, their use as medicaments and processes for¹their preparation | |
EG18730A (en) | Substituted tetralin, chromans and related compounds in the treatment of asthma, arthritis and related diseases | |
UA19782A (uk) | Спосіб одержаhhя біциклічhих складhих ефірів або їх фармацевтичhо прийhятhих солей | |
ATE175358T1 (de) | Behandlung des prämenstruellen oder späten lutealsphase-syndroms | |
DK217588D0 (da) | 17beta-(cyclopropylamino)-androst-5-en-3beta-olderivater, deres fremstilling og anvendelse som laegemidler | |
ATE102830T1 (de) | Methode zur behandlung des interstitiellen blasenentzuendung. | |
SE9603725D0 (sv) | New teatment | |
ATE307203T1 (de) | Verwendung eines anti-interleukin-9 antikörpers zur herstellung eines medikamentes zur behandlung von asthma | |
IT8719763A0 (it) | Analoghi retro-inversi della timopentina e dei suoi frammenti, il metodo per la loro sintesi ed il loro impiego per la preparazionedi composizioni farmaceutiche. | |
EP0318233A3 (fr) | Inhibiteurs d'assimilation de sérotonine et de norépinéphrine | |
ES483661A1 (es) | Procedimiento para la obtencion de derivados de 1,4-dihidro-piridina sila-sustituidos | |
IL114129A0 (en) | Composition for the treatment of nicotine craving and/or smoking withdrawal symptoms | |
EP0304294A3 (fr) | Taliscanine et autres aristolactames pour le traitement des maladies neurologiques, maladie de Parkinson, maladie d'Alzheimer et de l'impuissance | |
IL114130A0 (en) | Composition for the treatment of nicotine craving and/or smoking withdrawal symptoms | |
CA2002182A1 (fr) | Compositions pour le traitement du syndrome premenstruel ou de la phase luteinique tardive, et leur mode d'emploi | |
EP0356997A3 (fr) | Utilisation de buspirone pour préparer de compositions pharmaceutiques pour le traitement de l'asservissement aux drogues | |
CA2019745A1 (fr) | Preparation pour le traitement et la prevention des thromboses et des complications thromboemboliques, utilisation d'une telle preparation et methode de production | |
EP0260585A3 (en) | Bicyclic ketones, method for their production and aroma and/or flavour compositions containing said ketones |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): JP |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE CH DE FR GB IT LU NL SE |
|
AK | Designated states |
Kind code of ref document: A3 Designated state(s): JP |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): AT BE CH DE FR GB IT LU NL SE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1989912045 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1989912045 Country of ref document: EP |
|
WWG | Wipo information: grant in national office |
Ref document number: 1989912045 Country of ref document: EP |